Skip to main content
Izotropic Corporation logo

Izotropic Corporation — Investor Relations & Filings

Ticker · IZO ISIN · CA46604F1099 LEI · 529900IZ5PIVM7X6S027 CSE Manufacturing
Open in API
Filings indexed 368 across all filing types
Latest filing 2020-02-13 Capital/Financing Update
Country CA Canada
Listing CSE IZO

About Izotropic Corporation

https://izocorp.com/

Izotropic Corporation develops and commercializes diagnostic medical devices, specializing in advanced breast cancer detection technology. Its flagship product is IzoView, a dedicated Breast CT imaging platform. IzoView utilizes high-resolution, true 3D imaging without requiring breast compression, offering superior spatial resolution compared to traditional modalities. The system is purpose-built to improve diagnostic accuracy and patient comfort, particularly targeting the 50% of women with dense breast tissue where conventional screening tools are often inadequate. Izotropic is currently advancing IzoView through pivotal clinical studies toward product launch and commercialization.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is an announcement by Izotropic Corporation about raising $1.23 million from a warrant exercise program, including details on stock options issued and cancelled. It discusses financing activities such as warrant exercises and stock option issuances, which are capital raising and capital structure changes. There is no indication of a full financial report, earnings release, or regulatory filing. The document length is short (2851 characters) and it is clearly an update on financing activities rather than a report or announcement of a report publication. Therefore, the document fits best under Capital/Financing Update (CAP).
2020-02-13 English
News release - English.pdf
Regulatory Filings
2020-02-05 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a news release announcing a warrant exercise incentive program by Izotropic Corporation. It details the terms of the program, including exercise prices, expiry dates, and conditions for warrant holders. The content focuses on a capital raising activity through warrant exercises and incentives, which is a financing update. There are no financial statements, audit information, or detailed financial results presented. The document is not a report but an announcement of a financing-related program. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is over 5,000 characters and contains substantive information about the financing program, supporting a high confidence score.
2020-01-28 English
News release - English.pdf
Regulatory Filings
2020-01-23 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a corporate bulletin or informational release from Izotropic Corporation discussing the potential of AI in breast cancer detection, referencing a Google AI study, and describing the company's breast CT imaging technology and ongoing clinical trials. It contains no financial statements, no regulatory filings, no meeting materials, no voting results, no management or board changes, no earnings data, and no legal or merger information. The content is primarily promotional and informational about technology and research progress, with no indication of it being an official financial or regulatory report. The document length is 7,846 characters, which is relatively short and more consistent with a corporate update or press release rather than a formal report. It does not fit the definitions of any specific financial or regulatory filing categories such as Annual Report, Interim Report, Earnings Release, or Regulatory Filings. Given the nature and content, the best fitting category is Regulatory Filings (RNS) as a general corporate announcement or informational release that does not fit other categories.
2020-01-08 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings
2019-12-16 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.